PRESS RELEASE published on 10/31/2023 at 06:54, 1 year 7 months ago The dYdX Chain has Launched - Bridging and Staking Now Available
PRESS RELEASE published on 10/27/2023 at 18:15, 1 year 7 months ago Introducing DYDX - The L1 Token of the dYdX Chain
Published on 06/18/2025 at 15:15, 12 minutes ago Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
Published on 06/18/2025 at 15:00, 27 minutes ago iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Published on 06/18/2025 at 14:50, 37 minutes ago Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA
Published on 06/18/2025 at 14:30, 57 minutes ago Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones
Published on 06/18/2025 at 14:30, 57 minutes ago MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
Published on 06/18/2025 at 14:25, 1 hour 2 minutes ago Delivery Hero welcomes new Supervisory Board Member at 2025 Annual General Meeting
Published on 06/18/2025 at 10:33, 4 hours 54 minutes ago PNE’s 240 MW Khauta South photovoltaic project in South Africa reaches Final Project Development Milestone
Published on 06/18/2025 at 10:00, 5 hours 27 minutes ago Chat Tiddy Recognised at Cambridge University’s CHIA Conference for Its Innovative Companion-Based Language Learning Model
Published on 06/18/2025 at 14:21, 1 hour 6 minutes ago Definitieve resultaten van de kapitaalverhoging
Published on 06/18/2025 at 09:39, 5 hours 47 minutes ago Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips
Published on 06/18/2025 at 09:39, 5 hours 47 minutes ago First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips
